Semler Scientific (NASDAQ:SMLR) Shares Gap Down – Here’s Why

Semler Scientific, Inc. (NASDAQ:SMLR) shares gapped down prior to trading on Friday . The stock had previously closed at $61.15, but opened at $53.99. Semler Scientific shares last traded at $54.80, with a volume of 637,150 shares trading hands.

Analyst Ratings Changes

Separately, Lake Street Capital lifted their target price on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a report on Friday.

Semler Scientific Price Performance

The company has a market cap of $514.11 million, a price-to-earnings ratio of 27.05 and a beta of 1.18. The firm has a 50-day moving average price of $60.44 and a 200 day moving average price of $40.35.

Semler Scientific (NASDAQ:SMLR) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35. The business had revenue of $13.51 million for the quarter. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.

Institutional Investors Weigh In On Semler Scientific

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Cerity Partners LLC boosted its position in Semler Scientific by 91.5% in the third quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock valued at $31,689,000 after buying an additional 642,982 shares in the last quarter. Shariaportfolio Inc. acquired a new stake in shares of Semler Scientific during the 3rd quarter valued at $3,618,000. AQR Capital Management LLC grew its position in Semler Scientific by 150.1% during the 2nd quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock worth $4,833,000 after acquiring an additional 84,314 shares during the last quarter. Exchange Traded Concepts LLC increased its holdings in Semler Scientific by 345.8% in the 4th quarter. Exchange Traded Concepts LLC now owns 61,396 shares of the company’s stock worth $3,315,000 after purchasing an additional 47,625 shares in the last quarter. Finally, Crawford Fund Management LLC bought a new position in Semler Scientific in the third quarter valued at about $883,000. 49.37% of the stock is currently owned by institutional investors.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.